Emergent Overview
Company Headquarters: Maryland, US
Founded: 1998
Workforce: ~2,500
Company Working: Emergent is a global life sciences company focused on providing innovative preparedness and response solutions addressing accidental, deliberate, and naturally occurring Public Health Threats (PHTs). Its solutions include product portfolio, products that are under development (pipeline products), and contract development and manufacturing (“CDMO”). Revenues are generated by the sale and procurement of the company's product/product candidate portfolio, the provision of CDMO services to external customers, and non-dilutive contract and grant funding for research and development ("R&D") projects from various third-party sources
Strategy
Emergent invests in its current network of manufacturing facilities to enhance operational, quality, and compliance processes across the company in order to offer consistent delivery of products and services for both its own products and those of CDMO clients. It intends to focus on creating innovative solutions that meet unmet needs in the PHT area by expanding its pipeline of vaccines and therapeutic product candidates. It invests its own capital and secures government contracts, grants, or other non-dilutive funding to support pipeline expansion



